Cabaletta Bio, Inc. · NASDAQ:CABA
BlackRock, Inc. reported a 7.00% stake in Cabaletta Bio, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 7.00% stake in Cabaletta Bio, Inc., 3,397,260 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 3,397,260
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.00% | 3,397,260 |
Source
Related
- Cabaletta Bio, Inc.
- BlackRock, Inc.
- Cabaletta Bio, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026